New data inform decision‐making for breast cancer surgeries
Cancer · 01.08.2026 · 132 (15)
DOI: 10.1002/cncr.70488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 27.07.2026. Verfasst von Leah Lawrence. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, two studies presented at the American Society of Breast Surgeons Annual Meeting provide new comparative outcome data to assist with decision‐making for breast cancer surgeries. In addition, the HER2 ‐targeting TKI zongertinib showed a benefit in patients with advanced HER2 ‐mutant non–small cell lung cancer, and in comparison with the 2/20/20 model, use of the AQUILA criteria resulted in a 3‐fold greater number of patients with smoldering multiple myeloma who were classified as high risk.
Zitieren
APA
Lawrence, L. (2026). New data inform decision‐making for breast cancer surgeries. Cancer, 132(15). https://doi.org/10.1002/cncr.70488
Vancouver
Lawrence L. New data inform decision‐making for breast cancer surgeries. Cancer. 2026;132(15). doi:10.1002/cncr.70488
BibTeX
@article{Lawrence2026,
author = {Lawrence, Leah},
title = {New data inform decision‐making for breast cancer surgeries},
journal = {Cancer},
year = {2026},
volume = {132},
number = {15},
doi = {10.1002/cncr.70488}
}
EUVIMED